![]() |
市场调查报告书
商品编码
1938575
糖尿病袜市场 - 全球产业规模、份额、趋势、机会及预测(依产品类型、材料、销售管道、地区及竞争格局划分,2021-2031年)Diabetic Socks Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Material Used, By Sales Channel, By Region & Competition, 2021-2031F |
||||||
全球糖尿病袜市场预计将从 2025 年的 2.7091 亿美元成长到 2031 年的 4.0045 亿美元,复合年增长率为 6.73%。
这些特製袜子采用吸湿排汗布料、无缝袜头和宽鬆袜口,旨在促进血液循环,预防糖尿病患者足部溃疡。其市场成长主要受人口老化(易患神经病变)以及全球糖尿病患者人数不断增加(需要足部预防护理)的推动。根据国际糖尿病联盟 (IDF) 2024 年的报告,届时全球约有 5.89 亿成年人将患有糖尿病,凸显了防护鞋履对于避免截肢等严重后果的紧迫性。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 2.7091亿美元 |
| 市场规模:2031年 | 4.045亿美元 |
| 复合年增长率:2026-2031年 | 6.73% |
| 成长最快的细分市场 | 电子商务 |
| 最大的市场 | 北美洲 |
然而,与普通袜子相比,这些特殊产品高成本,这阻碍了市场成长。高昂的价格抑制了消费者的购买意愿,尤其是在低收入地区,那里的居民可支配收入有限,且预防性医用纺织品的保险覆盖不足。因此,儘管这些产品具有公认的健康益处,但经济因素仍然是推广应用的一大障碍,限制了其市场渗透率的进一步提高。
全球糖尿病盛行率的快速成长是推动该市场发展的主要因素,显着扩大了需要足部预防护理的患者群体。随着诊断率的上升,对促进血液循环和缓解压力的专用袜的需求也相应增长,这些袜子对于日常足部健康管理和溃疡预防至关重要。根据2024年11月发表在《柳叶刀》上的一项研究,全球糖尿病成人患者人数将达到8.28亿,超过先前的估计值。糖尿病患者数量的指数级增长直接推动了对用于预防慢性下肢併发症的防护袜的需求。
同时,人们对神经病变和足部卫生不良危害的认识不断提高,加速了相关产品的上市。医疗保健专业人员积极推荐糖尿病袜作为预防溃疡和截肢的关键措施,尤其是在高风险族群中。严重併发症的统计数据凸显了其紧迫性。例如,英国糖尿病协会在2024年2月报告称,英格兰每周有超过180例与糖尿病相关的截肢手术。此外,人口老化带来的脆弱性也支撑了市场。正如英国国家老龄委员会在2024年2月指出,约有29.2%的65岁及以上成年人患有糖尿病,这确保了老年人群对糖尿病袜的稳定需求。
医用专用纺织品的高成本是限制全球糖尿病袜市场成长的主要障碍。与普通袜子不同,糖尿病袜需要复杂的生产工艺,例如吸湿排汗面料混纺、无缝袜头设计以及宽鬆的袜口。这些技术要求增加了生产成本,导致零售价格上涨,从而疏远了对价格敏感的消费者。这种价格差异对患者构成了重大负担,尤其是在中低收入地区,他们必须自费承担足部预防保健费用,而无法获得医疗保险。
糖尿病本身带来的巨大经济负担加剧了治疗费用负担问题,消耗了原本可用于辅助治疗的财政资源。公立和私立医疗机构预算的压力迫使人们在基本药物和预防性辅助用品之间做出艰难抉择。根据国际糖尿病联盟预测,2024年,全球与糖尿病相关的医疗保健费用将至少达到1兆美元。如此巨大的经济负担限制了病患的购买力,阻碍了市场渗透,迫使人们优先考虑紧急医疗救治而非防护鞋。
智慧感测器技术的整合正在改变市场格局,使糖尿病袜从被动防护转变为主动、即时疾病管理工具。製造商正在开发将微型感测器嵌入织物的技术,以追踪足底压力和温度,在溃疡形成之前及早发现发炎。这项创新吸引了大量投资。根据 TechFundingNews 2025 年 1 月报道,美国公司 Siren 已成功资金筹措950 万美元,用于进一步开发其温度监测袜。这一趋势标誌着可穿戴医疗纺织品正与远端患者监护系统相结合,以降低长期治疗成本。
同时,抗菌奈米技术正逐渐成为产品差异化优势,满足了降低有下肢疾病史患者感染风险的迫切需求。为了抑制细菌和真菌的生长,製造商正在产品中添加银或铜浸渍纤维,以破坏病原体的细胞膜。这种持续保护的重要性体现在疾病的持续性上。 2025年9月,Medscape指出,糖尿病足溃疡的三年復发率约为58%,与进行性的復发率相当。因此,抗菌特性对于预防再次感染和维持高风险患者的长期缓解至关重要。
The Global Diabetic Socks Market is projected to expand from USD 270.91 Million in 2025 to USD 400.45 Million by 2031, reflecting a CAGR of 6.73%. These specialized socks utilizes moisture-wicking materials, seamless toes, and non-binding cuffs to enhance circulation and prevent ulcers in diabetic patients. Growth is largely driven by an aging demographic prone to neuropathy and a worldwide increase in diabetes cases, which necessitates preventive foot care. The International Diabetes Federation reported in 2024 that roughly 589 million adults globally live with diabetes, highlighting the urgent need for protective footwear to avert serious outcomes like amputation.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 270.91 Million |
| Market Size 2031 | USD 400.45 Million |
| CAGR 2026-2031 | 6.73% |
| Fastest Growing Segment | E-Commerce |
| Largest Market | North America |
However, market growth faces hurdles due to the high cost of these specialized products relative to standard socks. This price premium acts as a deterrent, especially in low-income areas where disposable income is scarce and insurance coverage for preventive medical textiles is often lacking. Consequently, economic limitations persist as a significant obstacle to widespread adoption, preventing broader market penetration even though the health benefits are well-established.
Market Driver
The surging global prevalence of diabetes acts as the primary driver for this market, significantly widening the pool of patients who need preventive foot care. As diagnosis rates climb, there is a proportional increase in demand for specialized hosiery designed to enhance circulation and minimize constriction, which is vital for managing daily foot health and averting ulcers. A study published in The Lancet in November 2024 revealed that the global adult population living with diabetes has reached 828 million, surpassing earlier estimates. This dramatic rise in the diabetic population directly fuels the demand for protective footwear to prevent chronic complications in the lower limbs.
Concurrently, heightened awareness regarding neuropathy and the dangers of poor foot hygiene is accelerating product adoption. Healthcare providers are actively advocating for diabetic socks as a crucial defense against ulcers and amputations, especially for high-risk groups. The urgency is underscored by severe complication statistics; for instance, Diabetes UK reported in February 2024 that over 180 diabetes-related amputations occur weekly in England. The market is further supported by the aging population's vulnerability, as the National Council on Aging noted in February 2024 that roughly 29.2% of adults over 65 have diabetes, ensuring consistent demand from the geriatric sector.
Market Challenge
The high cost of specialized medical textiles stands as the main obstacle to the growth of the Global Diabetic Socks Market. Unlike standard hosiery, these socks necessitate complex manufacturing techniques to integrate features like moisture-wicking blends, seamless toe closures, and non-binding cuffs. These technical demands inflate production costs, leading to a retail price premium that discourages price-sensitive buyers. This price gap forms a significant barrier, particularly in low-to-middle-income regions where patients frequently must cover the cost of preventive foot care out-of-pocket without insurance assistance.
The issue of affordability is exacerbated by the substantial economic burden of the disease itself, which drains financial resources that might otherwise be spent on ancillary care. The pressure on both personal and public health budgets necessitates difficult choices between essential medications and preventive accessories. According to the International Diabetes Federation, global health expenditures related to diabetes reached at least USD 1 trillion in 2024. This massive financial strain limits the purchasing power of patients, restricting market penetration as individuals are forced to prioritize immediate medical treatments over protective footwear.
Market Trends
The market is being transformed by the integration of smart sensor technology, which evolves diabetic hosiery from passive protection into active, real-time disease management tools. Manufacturers are embedding microsensors into fabrics to track foot pressure and temperature, facilitating the early detection of inflammation prior to ulcer formation. This innovation is drawing substantial investment; as reported by TechFundingNews in January 2025, US-based company Siren secured USD 9.5 million to advance its temperature-monitoring socks. This trend highlights a shift toward linking wearable medical textiles with remote patient monitoring systems to lower long-term treatment costs.
Parallel to this, the use of antimicrobial nanotechnology is emerging as a key product differentiator, addressing the critical need to lower infection risks in patients with previous lower limb issues. To counter bacterial and fungal growth, manufacturers are incorporating silver and copper-infused fibers that disrupt pathogen cell membranes. The importance of such continuous protection is evident in the persistence of the condition; Medscape noted in September 2025 that the three-year recurrence rate for diabetic foot ulcers is around 58%, comparable to aggressive cancers. Thus, antimicrobial properties are becoming indispensable for preventing re-infection and maintaining long-term remission in high-risk patients.
Report Scope
In this report, the Global Diabetic Socks Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Diabetic Socks Market.
Global Diabetic Socks Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: